SCHEMBL6325273

SCHEMBL6325273

Cc1[nH]c2ccc(C(=O)O)cc2c1Cc1ccc(OCc2ccccc2)cc1Cl

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN5 P54829 1/20 0.58
TRPM8 Q7Z2W7 1/20 0.53
POLB P06746 1/20 0.50
MRGPRX4 Q96LA9 3/20 0.47
MAPT P10636 3/20 0.46
NR4A2 P43354 2/20 0.45
NR4A1 P22736 1/20 0.44
NR4A3 Q92570 1/20 0.44
KDM4E B2RXH2 5/20 0.44
ALDH1A1 P00352 3/20 0.44
HPGD P15428 3/20 0.44
HSD17B10 Q99714 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
SRD5A2 P31213 1/20 0.44
S1PR1 P21453 1/20 0.44
PRKX P51817 1/20 0.44
ACVR1 Q04771 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6320131 0.92 TRPM8 (0.51) PTPN5TRPM8POLBMAPTKDM4E
SCHEMBL6319864 0.90 PTPN5 (0.58) PTPN5TRPM8POLBMRGPRX4NR4A2
SCHEMBL6322652 0.88 POLB (0.61) PTPN5POLBMAPTKDM4EALDH1A1
SCHEMBL5882137 0.86 PTPN5 (0.74) PTPN5TRPM8POLBMRGPRX4MAPT
SCHEMBL6318392 0.84 MCL1 (0.49) PTPN5TRPM8
SCHEMBL5881790 0.82 PTPN5 (0.58) PTPN5POLBMAPTNR4A2KDM4E
SCHEMBL6318627 0.82 PTPN5 (0.50) PTPN5TRPM8POLBMRGPRX4MAPT
SCHEMBL5881662 0.82 PTPN5 (0.53) PTPN5POLBMAPTKDM4EALDH1A1
SCHEMBL6319268 0.81 PTPN5 (0.52) PTPN5POLBKDM4EALDH1A1HPGD
SCHEMBL5881620 0.81 PTPN5 (0.57) PTPN5POLBMRGPRX4MAPTNR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050171185-A1 Indole derivatives FUJISAWA PHARMACEUTICAL CO., LTD., A JAPANESE CORPORATION 2005-08-04 US disclosed
CN-1150167-C Indole derivatives ����ҩƷ��ҵ��ʽ���� 2004-05-19 CN disclosed
CN-1303371-A Indole derivatives FUJISAWA PHARMACEUTICAL CO (JP) 2001-07-11 CN disclosed
EP-1070705-A1 INDOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-01-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171185-A1 Indole derivatives PDE5A, IGFBP5, HTR5A PTPN5 108/4885TRPM8 3042/4885POLB 3673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.